摘要
Herein, we report the structure-activity relationships within a series of mGlu(7) PAMs based on a pyrazolo[1,5-c]pyrimidine core with excellent CNS penetration (K(p)s > 1 and K-p,K-uu,s > 1). Analogues in this series proved to display a range of Group III mGlu receptor selectivity, but VU6005649 emerged as the first dual mGlu(7/8) PAM, filling a void in the Group III mGlu receptor PAM toolbox and demonstrating in vivo efficacy in a mouse contextual fear conditioning model.
- 出版日期2017-10